V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003972 | 310001677 | 1.75 | 105 | Palliative (P) | 2014-04-24 | 2014-05-17 | Vemurafenib | N | N | 310018979 | CAPECITABINE + CISPLATIN |
| 310003973 | 310001677 | 1.75 | 87.7 | null | null | 2014-03-05 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310018979 | CISPLATIN + ETOPOSIDE |
| 310003974 | 310001678 | null | 95.4 | Palliative (P) | null | 2013-12-10 | ECX | 02 | null | 310018981 | ECX |
| 310003975 | 310006739 | 1.82 | 67.3 | Palliative (P) | 2014-12-12 | 2016-02-12 | Oxaliplatin + Modified de Gramont | 02 | N | 310018982 | EOX |
| 310003976 | 310006739 | 1.54 | null | Curative (C) | 2013-10-23 | 2013-10-24 | Cisplatin + Docetaxel +Fluorouracil | null | null | 310018982 | ICON TRIAL |
| 310003977 | 310010378 | 1.58 | null | Disease modification (D) | 2017-04-27 | 2017-04-28 | CHOEP | null | null | 310018984 | CHOEP |
| 310003978 | 310011065 | null | null | Palliative (P) | null | 2017-04-16 | null | N | N | 310018986 | VEMURAFENIB |
| 310003979 | 310011065 | 1.79 | 70.4 | Palliative (P) | 2016-06-09 | 2016-06-28 | CISPLATIN + FLUOROURACIL | Y | N | 310018986 | EOX |
| 310003980 | 310001679 | 1.72 | 80.2 | Neo-adjuvant (N) | 2013-12-02 | 2013-12-18 | Mitomycin Intravesical | null | N | 310018990 | ICON TRIAL |
| 310003981 | 310006740 | 0 | 78 | Palliative (P) | 2015-05-04 | 2015-05-04 | GEM-P | N | N | 310018992 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003982 | 310006740 | 0 | 81.2 | Neo-adjuvant (N) | 2016-07-23 | 2016-08-07 | Hydroxycarbamide | Y | N | 310018992 | OXALIPLATIN + MDG |
| 310003983 | 310006740 | 1.69 | 80 | Palliative (P) | null | 2015-11-27 | IPILIMUMAB + NIVOLUMAB | N | N | 310018992 | IPILIMUMAB + NIVOLUMAB |
| 310003984 | 310001680 | 1.6 | 50 | null | null | 2016-06-27 | Dacarbazine | null | N | 310018997 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003985 | 310001681 | null | null | Palliative (P) | null | 2014-07-02 | Bexarotene | 2 | N | 310018998 | GEMCITABINE + PACLITAXEL |
| 310003986 | 310001681 | 1.59 | 86.35 | Neo-adjuvant (N) | 2013-07-16 | 2013-07-21 | Hydroxycarbamide | null | 2 | 310018998 | LIPOSOMAL DOXORUBICIN |
| 310003987 | 310009130 | 1.77 | 64.1 | Palliative (P) | 2014-02-16 | 2014-02-17 | IPILIMUMAB + NIVOLUMAB | 02 | N | 310019000 | CISPLATIN + ETOPOSIDE |
| 310003988 | 310010380 | null | null | Disease modification (D) | 2017-10-04 | 2017-10-04 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 310019005 | NOT MATCHED |
| 310003989 | 310010380 | 1.73 | 66.4 | Palliative (P) | null | 2013-01-23 | Liposomal Doxorubicin (Caelyx) | N | null | 310019005 | DACARBAZINE |
| 310003990 | 310001682 | 1.83 | null | null | 2015-02-13 | 2015-02-14 | Gemcitabine weekly | N | N | 310019009 | GEMCITABINE |
| 310003991 | 310001683 | 1.78 | 0 | Curative (C) | 2013-12-24 | 2013-12-24 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310019013 | OXALIPLATIN + MDG |
| 310003992 | 310001683 | 1.73 | 30 | Palliative (P) | 2016-07-31 | 2016-07-31 | Rituximab | 02 | N | 310019013 | LIPOSOMAL DOXORUBICIN |
| 310003993 | 310001684 | 1.75 | 83.9 | Palliative (P) | 2015-10-12 | 2015-10-12 | CHOEP - 21 days | N | N | 310019016 | BCG |
| 310003994 | 310001685 | 1.55 | 0 | Disease modification (D) | 2017-07-08 | 2017-07-10 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 310019019 | CISPLATIN + ETOPOSIDE |
| 310003995 | 310001685 | 1.69 | 0 | Disease modification (D) | 2017-01-02 | 2017-01-03 | CHOEP | 02 | N | 310019019 | CISPLATIN + FLUOROURACIL |
| 310003996 | 310001686 | 1.73 | null | Palliative (P) | null | 2017-09-03 | ECX | 02 | N | 310019023 | ECX |
| 310003997 | 310006744 | 1.72 | 63 | Neo-adjuvant (N) | 2014-12-30 | 2015-01-05 | GEM-P | N | N | 310019024 | MITOMYCIN INTRAVESICULAR |
| 310003998 | 310006744 | null | null | Disease modification (D) | 2015-01-09 | 2015-01-11 | Capecitabine + Oxaliplatin 21day | null | null | 310019024 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003999 | 310006744 | 0 | 0 | Palliative (P) | 2014-10-08 | 2014-10-10 | Imatinib 400mg | null | null | 310019024 | CAPECITABINE + CISPLATIN |
| 310004000 | 310011067 | 1.74 | 87.6 | Palliative (P) | 2016-11-11 | 2016-11-12 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 310019029 | GEMCITABINE |
| 310004002 | 310001688 | 1.6 | 65 | Palliative (P) | 2016-05-01 | 2016-05-06 | Vemurafenib | 02 | N | 310019035 | VEMURAFENIB |
| 310004003 | 310001689 | 0 | 61.7 | Disease modification (D) | 2014-01-02 | 2014-01-02 | Hydroxycarbamide | N | N | 310019036 | PACLITAXEL |
| 310004004 | 310001690 | 1.48 | 62.6 | Palliative (P) | 2016-04-23 | 2016-05-02 | Capecitabine + Cisplatin | 02 | N | 310019037 | OXALIPLATIN + MDG |
| 310004005 | 310001691 | 1.64 | 0 | null | 2017-05-01 | 2017-06-05 | CAPECITABINE + OXALIPLATIN | N | N | 310019038 | HYDROXYCARBAMIDE |
| 310004006 | 310001692 | null | 65.7 | Palliative (P) | 2016-06-24 | 2016-07-20 | Liposomal Doxorubicin 50mg/m2 | null | null | 310019045 | PACLITAXEL |
| 310004007 | 310001693 | 1.63 | 94.5 | Palliative (P) | 2015-06-11 | 2015-06-29 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310019046 | VEMURAFENIB |
| 310004008 | 310001694 | null | null | Curative (C) | 2016-07-03 | 2016-07-04 | Mitomycin Intravesical | 02 | N | 310019048 | RITUXIMAB |
| 310004009 | 310006745 | 1.47 | 3.7 | Curative (C) | 2014-06-20 | 2014-06-22 | Rituximab (Maintenance) | N | N | 310019052 | LIPOSOMAL DOXORUBICIN |
| 310004010 | 310001695 | null | 114.4 | Palliative (P) | 2016-04-13 | 2016-04-16 | ECX | 2 | N | 310019053 | ECX |
| 310004011 | 310001696 | 1.63 | 62 | Palliative (P) | null | 2017-06-18 | Imatinib 400mg | N | N | 310019054 | PACLITAXEL |
| 310004012 | 310001697 | 1.62 | 73.6 | Disease modification (D) | 2013-03-15 | 2013-11-19 | Rituximab | N | N | 310019055 | DACARBAZINE |
| 310004013 | 310001698 | 1.8 | 84.5 | Palliative (P) | 2014-02-05 | 2014-02-15 | Liposomal Doxorubicin (Caelyx) | N | N | 310019058 | PACLITAXEL |
| 310004014 | 310001698 | null | 74 | null | 2016-06-21 | 2016-06-23 | ICON8 TRIAL | N | null | 310019058 | IMATINIB |
| 310004015 | 310001698 | 1.7 | 89 | Curative (C) | 2015-09-29 | 2015-09-29 | Oxaliplatin + Modified de Gramont | N | N | 310019058 | CAPECITABINE + OXALIPLATIN |
| 310004016 | 310010382 | 1.81 | 70.5 | Adjuvant (A) | 2015-11-29 | 2015-12-22 | Liposomal Doxorubicin 50mg/m2 | 02 | N | 310019063 | MITOMYCIN INTRAVESICULAR |
| 310004017 | 310010382 | 1.47 | 75 | Adjuvant (A) | 2015-01-22 | 2015-01-30 | null | N | N | 310019063 | NOT MATCHED |
| 310004018 | 310001699 | null | 101 | Palliative (P) | 2015-01-08 | 2015-01-18 | Liposomal Doxorubicin 40mg/m2 | null | Y | 310019066 | BEXAROTENE |
| 310004019 | 310001699 | 1.54 | 77 | Palliative (P) | 2016-12-09 | 2017-12-10 | Capecitabine | N | N | 310019066 | VEMURAFENIB |
| 310004020 | 310001700 | null | null | Curative (C) | 2018-02-01 | 2018-02-15 | Mitomycin Intravesical | N | N | 310019070 | DACARBAZINE |
| 310004021 | 310001701 | 1.73 | 107.5 | Neo-adjuvant (N) | 2013-07-24 | 2013-08-01 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 310019071 | PACLITAXEL |
| 310004022 | 310001701 | null | null | Palliative (P) | null | 2013-11-21 | IPILIMUMAB + NIVOLUMAB | Y | null | 310019071 | IPILIMUMAB + NIVOLUMAB |